Name: Can-Fite BioPharma
Address: 10 Bareket Street, Petah-Tikva, 49170, ISRAEL
Telephone: +972-3-9241114

Filing Type:

Year:

Date	Form	Description	Pages
04/03/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	3
03/28/24	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-2.1 EX-4.9 EX-12.1 EX-13.1 EX-15.1 EX-97.1	135
03/28/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	4
03/11/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	2
02/28/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	3
02/14/24	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	7
01/30/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	2
01/29/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	2
01/05/24	EFFECT	Notice of Effectiveness	1
01/03/24	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.	1